DEFINED DAILY DOSES IN RELATION TO HYPOLIPEMIC EFFICACY OF LOVASTATIN, PRAVASTATIN, AND SIMVASTATIN

被引：82
|
作者：
ILLINGWORTH, DR
ERKELENS, DW
KELLER, U
THOMPSON, GR
TIKKANEN, MJ
机构：
[1] UNIV UTRECHT HOSP, DEPT ENDOCRINOL, UTRECHT, NETHERLANDS
[2] KANTONSSPITAL, DEPT INTERNAL MED, CH-4031 BASEL, SWITZERLAND
[3] HAMMERSMITH HOSP, MRC, LIPOPROT TEAM, LONDON W12 0HS, ENGLAND
[4] UNIV HELSINKI HOSP, DEPT INTERNAL MED, HELSINKI, FINLAND
来源：
LANCET | 1994年 / 343卷 / 8912期
关键词：
D O I：
10.1016/S0140-6736(94)92945-9
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：1554 / 1555
页数：2
相关论文
共 50 条
  • [31] High doses of simvastatin, pravastatin, and cholesterol reduce brain cholesterol synthesis in guinea pigs
    Lütjohann, D
    Stroick, M
    Bertsch, T
    Kühl, S
    Lindenthal, B
    Thelen, K
    Andersson, U
    Björkhem, I
    von Bergmann, K
    Fassbender, K
    STEROIDS, 2004, 69 (06) : 431 - 438
  • [32] WHO defined daily doses versus hospital-adjusted defined daily doses: impact on results of antibiotic use surveillance
    Haug, Jon Birger
    Reikvam, Asmund
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2013, 68 (12) : 2940 - 2947
  • [33] Discrepancies between prescribed daily doses and WHO defined daily doses of antibacterials at a university hospital
    Muller, A
    Monnet, DL
    Talon, D
    Henon, T
    Bertrand, X
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 61 (05) : 585 - 591
  • [34] Action of lovastatin, simvastatin, and pravastatin on sterol synthesis and their antiproliferative effect in cultured myoblasts from human striated muscle
    vanVliet, AK
    NegreAminou, P
    vanThiel, GCF
    Bolhuis, PA
    Cohen, LH
    BIOCHEMICAL PHARMACOLOGY, 1996, 52 (09) : 1387 - 1392
  • [35] COMPARATIVE EFFICACY AND TOLERABILITY OF 5 AND 10 MG SIMVASTATIN AND 10 MG PRAVASTATIN IN MODERATE PRIMARY HYPERCHOLESTEROLEMIA - SIMVASTATIN PRAVASTATIN EUROPEAN STUDY-GROUP
    STEINHAGENTHIESSEN, E
    CARDIOLOGY, 1994, 85 (3-4) : 244 - 254
  • [36] Relation between Defined Daily Doses (DDD) and Prescribed Daily Doses: A 3-Month Analysis of Outpatient Data from a Statutory Health Insurance Company
    Grimmsmann, T.
    Himmel, W.
    GESUNDHEITSWESEN, 2010, 72 (07) : 412 - 418
  • [37] Assignment of Canadian Defined Daily Doses and Canadian Defined Course Doses for Quantification of Antimicrobial Usage in Cattle
    Larde, Helene
    Dufour, Simon
    Archambault, Marie
    Leger, David
    Loest, Daleen
    Roy, Jean-Philippe
    Francoz, David
    FRONTIERS IN VETERINARY SCIENCE, 2020, 7
  • [38] Accumulation of lovastatin, but not pravastatin, in the blood of cyclosporine-treated kidney graft patients after multiple doses
    Olbricht, C
    Wanner, C
    Eisenhauer, T
    Kliem, V
    Doll, R
    Boddaert, M
    OGrady, P
    Krekler, M
    Mangold, B
    Christians, U
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1997, 62 (03) : 311 - 321
  • [39] COMPARISON OF THE SHORT-TERM EFFICACY AND TOLERABILITY OF LOVASTATIN AND PRAVASTATIN IN THE MANAGEMENT OF PRIMARY HYPERCHOLESTEROLEMIA
    MCPHERSON, R
    BEDARD, J
    CONNELLY, P
    CURNEW, G
    DAVIGNON, J
    ECHENBERG, D
    LAVIN, P
    LEITER, L
    LENIS, J
    MCQUEEN, M
    MONTIGNY, M
    MUNOZ, C
    OLEARY, T
    OOI, T
    ROULEAU, JL
    SPENCE, D
    TAN, M
    THEROUX, P
    CLINICAL THERAPEUTICS, 1992, 14 (02) : 276 - 291
  • [40] Comparative efficacy and tolerability of low-dose pravastatin versus lovastatin in patients with hypercholesterolemia
    Strauss, WE
    Lapsley, D
    Gaziano, JM
    AMERICAN HEART JOURNAL, 1999, 137 (03) : 458 - 462
12345